Fulgent Genetics, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Fulgent Genetics has filed a definitive proxy statement with the SEC, signaling preparations for an upcoming shareholder meeting.
NASDAQ
Fulgent Genetics sets date and agenda for its 2025 Annual Meeting of Stockholders, including director elections and executive compensation approval.
NASDAQ
Fulgent Genetics has filed a definitive proxy statement with the SEC, signaling upcoming shareholder actions.
NASDAQ
Fulgent Genetics announces its 2024 Annual Meeting of Stockholders to be held on May 16, 2024, focusing on director elections, auditor ratification, and executive compensation approval.